MBB Public Markets I LLC acquired a new position in CME Group Inc. (NASDAQ:CME - Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 1,195 shares of the financial services provider's stock, valued at approximately $317,000.
Other institutional investors and hedge funds have also modified their holdings of the company. Heartland Bank & Trust Co purchased a new stake in shares of CME Group during the first quarter worth about $377,000. Catalyst Capital Advisors LLC boosted its holdings in CME Group by 256.9% in the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock valued at $971,000 after purchasing an additional 2,636 shares during the last quarter. OMNI 360 Wealth Inc. acquired a new position in CME Group in the 1st quarter valued at about $367,000. Fulcrum Equity Management acquired a new position in shares of CME Group in the 1st quarter worth approximately $258,000. Finally, AIA Group Ltd boosted its position in shares of CME Group by 17.8% during the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider's stock worth $4,416,000 after purchasing an additional 2,510 shares during the period. Hedge funds and other institutional investors own 87.75% of the company's stock.
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on the stock. Citigroup increased their price objective on shares of CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a research report on Thursday, July 3rd. Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Piper Sandler lifted their price target on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 15th. Finally, UBS Group lowered their price objective on shares of CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a research report on Monday. Four equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $260.60.
Check Out Our Latest Research Report on CME Group
Insider Buying and Selling
In other news, Director William R. Shepard acquired 256 shares of the business's stock in a transaction dated Wednesday, June 25th. The stock was acquired at an average price of $270.53 per share, with a total value of $69,255.68. Following the completion of the transaction, the director directly owned 258,196 shares in the company, valued at approximately $69,849,763.88. This represents a 0.10% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the business's stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their position. The disclosure for this sale can be found here. Insiders own 0.30% of the company's stock.
CME Group Price Performance
CME traded down $0.08 during midday trading on Friday, reaching $262.30. 1,537,684 shares of the company's stock were exchanged, compared to its average volume of 1,837,493. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $94.53 billion, a PE ratio of 25.39, a P/E/G ratio of 4.75 and a beta of 0.43. The business's 50-day moving average price is $273.60 and its 200 day moving average price is $270.29. CME Group Inc. has a 1-year low of $212.38 and a 1-year high of $290.79.
CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm's quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.56 earnings per share. As a group, equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's payout ratio is currently 48.40%.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.